Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018 Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …
News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
News
2018

Seven pharma trends for 2018

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …
Feature
attribution-icon-2888829_640

The rare disease climate in Europe

December 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

Continuing on from this week’s earlier feature on the rare disease situation in the US, Pharmafile moves its attention onto …
Feature
gsk_boronia_australia

GSK forced to pay back £1.5m to Scottish Government after recent job cuts

December 20, 2017 Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, pharma

British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure …
News
allergan

Allergan and Gedeon Richter’s Vraylar posts strong Phase 3 data in bipolar depression

December 19, 2017 Manufacturing and Production, Research and Development Allergan, Gedeon Richter, Vraylar, bipolar, bipolar depression, pharma

Vraylar (cariprazine), a drug developed as part of a partnership between Allergan and Gedeon Richter, has demonstrated strong results at …
News

Boehringer scoops schizophrenia candidates for €627.5m

December 19, 2017 Manufacturing and Production, Sales and Marketing Autifony, Boehringer Ingelheim, biotech, drugs, pharma, pharmaceutical

Boehringer Ingelheim has moved early to secure an exclusive option on Autifony’s lead candidate for the treatment of schizophrenia, AUT00206, …
News
homeopathy-1063292_640

FDA pledges to crack down on homeopathy treatments

December 19, 2017 Manufacturing and Production, Sales and Marketing FDA homeopathy, US, pharma

Following in the steps of authorities in the European Union, Australia and the United Kingdom, the FDA has pledged to …
News
doctor-563428_960_720

100,000 vacancies contribute to NHS crisis

December 19, 2017 Manufacturing and Production, Medical Communications NHS, UK, biotech, drugs, nurses, pharma, pharmaceutical

Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …
News
novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017 Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …
News
rare-disease-2888820_960_720

Rare disease medicines access faces a perfect storm

December 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …
News
teva_copy

Fierce local opposition to Teva’s restructure efforts

December 15, 2017 Manufacturing and Production, Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …
News
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

December 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …
Feature
mundipharma_4_204_of_291

Mundipharma names new President and CEO

December 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Napp, Napp Pharmaceuticals, appointment

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026